We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
1326
CALL
Skyworks Solutions
SWKS
$10.3B
$13.7M 0.01%
144,300
-46,700
-24% -$4.87M
JAZZ icon
1327
Jazz Pharmaceuticals
JAZZ
$15.8B
$13.7M 0.01%
101,692
-549,231
-84% -$76.2M
RRR icon
1328
Red Rock Resorts
RRR
$3.76B
$13.7M 0.01%
405,799
-52,724
-11% -$1.47M
GES
1329
DELISTED
Guess Inc
GES
$13.7M 0.01%
810,618
+627,375
+342% +$10.4M
EBAY icon
1330
eBay
EBAY
$46.2B
$13.7M 0.01%
362,274
-571,820
-61% -$21.2M
RARE icon
1331
Ultragenyx Pharmaceutical
RARE
$2.57B
$13.7M 0.01%
294,360
+269,271
+1,073% +$13.2M
WHR icon
1332
CALL
Whirlpool
WHR
$2.72B
$13.6M 0.01%
80,800
-133,100
-62% -$22.6M
BBBY
1333
PUT
Bed Bath & Beyond
BBBY
$419M
$13.6M 0.01%
283,370
+215,223
+316% +$7.77M
UNG icon
1334
United States Natural Gas Fund
UNG
$494M
$13.6M 0.01%
145,670
+82,826
+132% +$8.01M
HCA icon
1335
HCA Healthcare
HCA
$88.1B
$13.6M 0.01%
+154,594
New +$12.4M
NUE icon
1336
CALL
Nucor
NUE
$61.3B
$13.6M 0.01%
213,500
-55,600
-21% -$3.25M
COR icon
1337
PUT
Cencora
COR
$59.4B
$13.6M 0.01%
147,600
+68,800
+87% +$5.69M
XOG
1338
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$13.6M 0.01%
946,963
-2,124,311
-69% -$32.4M
CPB icon
1339
Campbell Soup
CPB
$6.94B
$13.5M 0.01%
281,521
-258,175
-48% -$12.3M
CDNS icon
1340
Cadence Design Systems
CDNS
$89.7B
$13.5M 0.01%
323,533
-1,661,548
-84% -$71.4M
LUMN icon
1341
PUT
Lumen
LUMN
$6.66B
$13.5M 0.01%
810,100
+385,600
+91% +$6.54M
TFC icon
1342
CALL
Truist Financial
TFC
$64.8B
$13.5M 0.01%
271,200
-51,400
-16% -$2.48M
ICE icon
1343
PUT
Intercontinental Exchange
ICE
$86.8B
$13.5M 0.01%
190,800
+165,300
+648% +$11.3M
MOS icon
1344
PUT
The Mosaic Company
MOS
$6.93B
$13.5M 0.01%
524,600
-120,300
-19% -$2.76M
IYR icon
1345
iShares US Real Estate ETF
IYR
$4.59B
$13.4M 0.01%
165,846
+144,983
+695% +$11.8M
EEFT icon
1346
Euronet Worldwide
EEFT
$2.72B
$13.4M 0.01%
159,414
+143,558
+905% +$13.3M
SHPG
1347
PUT
DELISTED
Shire pic
SHPG
$13.4M 0.01%
86,400
+26,200
+44% +$3.88M
BB icon
1348
PUT
BlackBerry
BB
$5.21B
$13.4M 0.01%
1,196,600
+418,400
+54% +$4.57M
GAP
1349
The Gap Inc
GAP
$7.42B
$13.3M 0.01%
391,148
+277,982
+246% +$8.29M
INFO
1350
DELISTED
IHS Markit Ltd. Common Shares
INFO
$13.3M 0.01%
294,782
+266,137
+929% +$11.7M

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.